Ebv-associated Lymphomas

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-10-30
Clinical Trial Update: KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial [EARLY_Phase 1]
KSD-101 Therapy for EBV-associated Lymphomas, an exploratory early-phase trial, has been withdrawn. The sponsor is Kousai Bio Co., Ltd.